Press Release: Datopotamab-Deruxtecan Demonstrates Survival Benefit in First-Line Metastatic Triple-Negative Breast Cancer

Datopotamab-Deruxtecan

OncoDaily Party Berlin 2025

OncoDaily Party Berlin 2025

2025 Nobel Prize in Physiology or Medicine: Peripheral Immune Tolerance, FOXP3, and the Future of Immunotherapy

2025 Nobel Prize in Physiology or Medicine: Peripheral Immune Tolerance, FOXP3, and the Future of Immunotherapy

Nicholas DeVito: The Importance and Urgency of Robust NIH and NCI Funding

Nicholas DeVito,

Yelak Biru: The Age of the Tech-Empowered Patient Partnership

Yelak Biru

100 Influential People in Oncology 2025 - Nominations are Open!

100 Influential People in Oncology 2025

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025

100 Influential Women in Oncology

Amol Akhade: New Molecules to Look Forward to in GI Cancers at ESMO 2025 

Amol Akhade

OncoCalendar

ERROR 404

It looks like nothing was found at this location. Maybe try one of the links or a search?